TITLE

Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in India

AUTHOR(S)
Padmapriyadarsini, Chandrasekaran; Kumar, S. Ramesh; Terrin, Norma; Narendran, Gopalan; Menon, Pradeep A.; Ramachandran, Geetha; Subramanyan, Sudha; Venkatesan, Perumal; Wanke, Christine; Swaminathan, Soumya
PUB. DATE
February 2011
SOURCE
Clinical Infectious Diseases;2/15/2011, Vol. 52 Issue 4, p540
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Our aim was to study the incidence and pattern of dyslipidemia among human immunodeficiency virus (HIV)-infected patients with tuberculosis (TB) who received once-daily antiretroviral therapy (ART). Methods. Antiretroviral-naive HIV-infected patients with TB were recruited to a trial of once-daily nonnucleoside reverse-transcriptase inhibitor (NNRTI)-based ART and treated with rifampicin-based thrice-weekly antituberculosis treatment (ATT); participants were randomized to receive didanosine (250/400 mg) and lamivudine (300 mg) with either efavirenz (600 mg) or nevirapine (400 mg) once-daily after an intensive phase of ATT. Fasting triglyceride (TG) level, total cholesterol (TC) level, low-density cholesterol (LDL-c) level and high-density cholesterol (HDL-c) level were measured at baseline and at 6 and 12 months. Lipid levels at 6 and 12 months were compared with baseline values with use of repeatedmeasures analyses. McNemar test was used to compare the proportion of patients with lipid abnormality at baseline versus at 12 months, and χ² test was used to compare between the 2 groups. Results. Of 168 patients (79% men; mean age, 36 years; mean weight, 42 kg; median CD41 cell count, 93 cells/ mm³), 104 received efavirenz-based ART, and 64 received nevirapine-based ART. After 6 months, TC levels increased by 49 mg/dL, LDL-c levels by 30 mg/dL, and HDL-c levels increased by 18 mg/dL (P < .001 for all). At baseline and at 12 months, TC was >200 mg/dL for 1% and 26% of patients, respectively; LDL-c level was >130 mg/ dL for 3% and 23%, respectively; HDL-c level was <40 mg/dL for 91% and 23%, respectively; and blood glucose level was >110 mg/dL for 14% and 13%, respectively. TC level >200 mg/dL was more common among patients who received efavirenz than among those who received nevirapine (32% vs 16%; P = .04). Conclusions. HIV-infected patients with TB who initiate NNRTI-based ART undergo complex changes in lipid profile, highlighting the importance of screening and treating other cardiovascular disease risk factors in this population.
ACCESSION #
57754765

 

Related Articles

  • Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Bergersen, B. M.; Sandvik, L.; Bruun, J. N.; Tonstad, S. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2004, Vol. 23 Issue 8, p625 

    Highly active antiretroviral therapy (HAART) may induce dyslipidemia and thus increase the risk of future cardiovascular heart disease (CHD). In this cross-sectional study performed in 2000–2001, the prevalence of a Framingham CHD risk score of >20% in HIV-positive individuals treated or...

  • Multiple-Dose Pharmacokinetics of Efavirenz with and without the Use of Rifampicin in HIV-Positive Patients. Matteelli, Alberto; Regazzi, Mario; Villani, Paola; De Iaco, Giuseppina; Cusato, Maria; Carvalho, Anna Cristina C.; Caligaris, Silvio; Tomasoni, Lina; Manfrin, Maria; Capone, Susanna; Carosi, Giampiero // Current HIV Research;Jul2007, Vol. 5 Issue 3, p349 

    Rifampicin (RIF) decreases serum concentrations of several antiretroviral drugs. We carried out a prospective, comparative study to define efavirenz (EFV) pharmacokinetics in 16 cases and 13 controls. Cases were HIV and tuberculosis (TB) co-infected adults assuming RIF 600 mg once daily and EFV...

  • Clinical and radiological deterioration in a patient with AIDS. De Backer, A. I.; Mortelé, K. J.; Bomans, P.; De Keulenaer, B. L.; Vanschoubroeck, I. J.; Kockx, M. M.; Mortelé, K J // European Radiology;Nov2005, Vol. 15 Issue 11, p2264 

    Paradoxical clinical deterioration of miliary tuberculosis, characterized by pulmonary and abdominal manifestations, is reported in a patient with the acquired immunodeficiency syndrome, after initiation of treatment with highly active antiretroviral therapy. Paradoxical reaction was attributed...

  • Determinants of Immune Reconstitution Inflammatory Syndrome in HIV Type 1-Infected Patients with Tuberculosis after Initiation of Antiretroviral Therapy. Breton, Guillaume; Duval, Xavier; Estellat, Candice; Poaletti, Xavier; Bonnet, Daniel; Mvondo, David Mvondo; Longuet, Pascale; Leport, Catherine; Vildé, Jean-Louis // Clinical Infectious Diseases;12/1/2004, Vol. 39 Issue 11, p1709 

    Immune reconstitution inflammatory syndrome (IRIS) occurred in 16 of 37 antiretroviral-naive patients who were treated subsequently for tuberculosis and human immuno-deficiency virus (H IV) type 1 infection. IRIS was related to increases in the CD4 cell percentage and in the ratio of CD4 cells...

  • Improved Lipid Profiles and Maintenance of Virologic Control in Heavily Pretreated HIV-Infected Patients Who Switched from Stavudine to Tenofovir Treatment. Schewe, Carl Knud; Maserati, Renato; Wassmer, Gernot; Adam, Axel; Weitner, Lutwin // Clinical Infectious Diseases;1/1/2006, Vol. 42 Issue 1, p145 

    A retrospective chart analysis of 66 human immunodeficiency virus type 1 (HIV-1)-infected patients whose treatment was switched from stavudine to tenofovir without any other treatment changes was conducted. The mean total cholesterol values decreased significantly within 3 months after the...

  • Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy-Related Lipodystrophy. Nasi, Milena; Guaraldi, Giovanni; Orlando, Gabriella; Durante, Caterina; Pinti, Marcello; Nemes, Elisa; Nardini, Giulia; Passarino, Giuseppe; Cocchi, Marina; Esposito, Roberto; Mussini, Cristina; Cossarizza, Andrea // Clinical Infectious Diseases;10/1/2008, Vol. 47 Issue 7, p962 

    Background. The combination of different point mutations in mitochondrial DNA (mtDNA), which are defined as haplogroups, may cause modification in organelle function and may be involved in several pathologies. We analyzed the distribution of mtDNA polymorphisms in human immunodeficiency virus...

  • Barriers to Initiation of Antiretrovirals during Antituberculosis Therapy in Africa. Pepper, Dominique J.; Marais, Suzaan; Wilkinson, Robert J.; Bhaijee, Feriyl; De Azevedo, Virginia; Meintjes, Graeme // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Background: In the developing world, the principal cause of death among HIV-infected patients is tuberculosis (TB). The initiation of antiretroviral therapy (ART) during TB therapy significantly improves survival, however it is not known which barriers prevent eligible TB patients from...

  • Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Levine, Beth; Chaisson, Richard E.; Levine, B; Chaisson, R E // Annals of Internal Medicine;5/15/91, Vol. 114 Issue 10, p861 

    Objective: To assess the clinical features and response to therapy of Mycobacterium kansasii infection in patients with human immunodeficiency virus (HIV) infection.Design: We reviewed the records of all patients with M. kansasii and HIV infection treated between...

  • Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007. Taarnhøj, Gry A.; Engsig, Frederik N.; Ravn, Pernille; Johansen, Isik S.; Larsen, Carsten S.; Røge, Birgit; Andersen, Aase B.; Obel, Niels // BMC Pulmonary Medicine;2011, Vol. 11 Issue 1, p26 

    Background: Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and late Highly Active Antiretroviral Therapy (HAART) (2000-2007) periods....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics